Global Cancer Monoclonal Antibodies Market Research Report 2021-2025: Focus on Naked Monoclonal Antibodies & Conjugated and Bi-specific Monoclonal Antibodies - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 30, 2021--
The “Global Cancer Monoclonal Antibodies Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.
The cancer monoclonal antibodies market is poised to grow by $33.1 bn during 2021-2025, progressing at a CAGR of 8.23%
The market is driven by the increase in demand for ADCs and awareness and initiatives taken by vendors and government.
The report on cancer monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The cancer monoclonal antibodies market analysis includes the type segment and geographic landscape.
This study identifies the strong R&D pipeline as one of the prime reasons driving the cancer monoclonal antibodies market growth during the next few years.
The publisher’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer monoclonal antibodies market vendors that include Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA.
Also, the cancer monoclonal antibodies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Key Topics Covered:
- Market overview
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Naked monoclonal antibodies - Market size and forecast 2020-2025
- Conjugated and bi-specific monoclonal antibodies - Market size and forecast 2020-2025
- Market opportunity by Type
- Geographic segmentation
- Geographic comparison
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
- Landscape disruption
- Vendors covered
- Market positioning of vendors
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Inc.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
For more information about this report visit https://www.researchandmarkets.com/r/zlgit
View source version on businesswire.com:https://www.businesswire.com/news/home/20210830005474/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH ONCOLOGY OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 08/30/2021 12:20 PM/DISC: 08/30/2021 12:21 PM